Thursday, June 30, 2016

Contraceptive Drugs and Devices Market Analysis, Size, Share Growth and Forecast 2012 To 2020: Hexa Research

Contraceptive drugs and devices market is expected to grow over the forecast period owing to the increasing prevalence of sexually transmitted diseases such as HIV & HPV and growing population. The other drivers of this market are increasing government & NGO’s programs against the abortion, social & political consideration, and changing lifestyle. Contraceptive drugs & devices are the commonly known for birth and fertility control and are used to avoid pregnancy. Function of these devices & drugs is to change ovulation mechanism by acting as a physical barrier between ovum and sperm. Lack of contraception results have impacted on healthcare costs due to the unwanted abortions and pregnancies. The usage, planning and provisions of contraceptives are known as family planning. There are various advantages attached to the contraceptive drugs & devices as it helps in the prevention of spread of sexually transmitted diseases. Family planning includes application of intra-uterine devices, sterilization, hormonal barrier as a method for birth control. Apart from these, there are emergency controls, dual protection and behavioral are available for prevention of pregnancy. Global market for contraceptives encompasses female contraceptive devices, male contraceptive devices, and vaginal, oral, and injectable contraceptive drugs. These contraceptive devices and drugs are available globally in almost all the outlets ranging from chemists, pharmacies, fertility centers and reproductive health centers. All the sexually active females at childbearing age are at a risk of unwanted pregnancies due to unsafe sex. There has been tremendous growth in the sexually transmitted diseases sector and the global population, due to the lack of awareness about the contraceptive drugs and devices. All these have generated awareness among the people to curb unplanned and unwanted pregnancies. This market has a huge unmet opportunity over the forecast period. 

Browse Detail Report with TOC @

Product Insights
Contraceptive drugs and devices market is segmented on the basis of product types into contraceptive drugs, female contraceptive devices, and male contraceptive devices. Among these, largest share is held by contraceptive drugs as of 2014, as it is easiest method of contraception. There has been lot of technological advancements in contraceptive drugs such as as development of emergency oral contraceptive pills. These contraceptive drugs are used for preventing unwanted pregnancy. These drugs are composition of one or more synthetic female sex hormones like progestin or progestin and estrogen. So it prevents pregnancy by blocking the normal and complex process of ovulation..It helps by prohibiting implantation of male hormones within the uterus, if it is taken within 2-3 days. Simplicity of their usage makes it prominent contraceptive in the market. The other forms of contraceptive drugs are injectable and topical, had also witnessed strong growth rate. Moreover, the contraceptive drugs and devices market has witnessed growth due to the introduction of cheap contraceptives such as Pill-Plus, AG200-15 Contraceptive Patch and Sino-Implant (II). Female contraceptive devices are the fastest growing market.  This market is further classified into, sub-dermal contraceptive implants, female condoms, contraceptive vaginal rings, intrauterine devices, contraceptive sponges, contraceptive diaphragm and non-surgical permanent contraception device. 
Regional Insights
Geographically, the Contraceptive drugs and devices market is studied with respect to four regions such as North America, Europe, Asia Pacific and RoW. Among these, North America and Europe is dominating the whole market owing to its sophisticated healthcare infrastructure, increasing awareness, availability of contraceptive drugs & devices, technologically advanced systems, and government initiatives. Over the forecast period, most of the domestic and international players are focusing on the emerging market, such as China, India, as these markets are lucrative by nature, and owe towards untapped opportunity, and these countries are growing rapidly in the contraceptive drugs and devices market. 
Request a Sample copy of This Report @ http://www.hexaresearch.com/sample/177
Competitive Insights
The major players in the, Contraceptive drugs and devices market are Merck & Co., Bayer Healthcare AG, Warmer Chilcott Company inc., Church & Dwight Co. Inc., Pfizer Inc., Agile Therapeutics Inc., Mayer Laboratories Inc., BioSante Pharmaceuticals, Teva Pharmaceutical Industries Ltd, and Pantarhei Bioscience B.V.
Table of Contents

Chapter 1. Executive Summary
1.1. Contraceptive - Industry Summary & Critical Success Factors (CSFs)

Chapter 2. Contraceptive Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Contraceptive Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Contraceptive - Company Market Share Analysis, 2013
2.7. Contraceptive market PESTEL Analysis, 2013


About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw    
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Emerging Insulin Drug and Delivery Technologies Market Size, Industry Trends And Forecast, 2013 To 2019

Globally, emerging technologies in the insulin drug and delivery field have shown potential in the diabetes market, with enhanced glucose control, along with well-accepted newer delivery methods. Contemporary industries, market players and research institutes have begun to explore novel methods for diabetes control in adults, leading to a steady market growth for these technologies.
Research and development spending, patent expiries, increasing competition and emerging technologies are expected to support the growth of this market. Technological advancements, new product launches, increased awareness and early detection of the disease have further influenced the market to develop in the foreseeable future.
Browse Detail Report with TOC @

The global market for insulin drug and delivery devices was estimated at USD 24.12 billion in 2012. Further the overall insulin drug and device market reached USD 25.72 billion by 2013 and is expected to grow at a CAGR of 9.6% from 2013 to 2019.
This research report provides comprehensive market statistics and forecast for key segments, and provides complete industry landscape including drivers, restraints, regulatory scenario, technology trends and future opportunities. The report also provides detailed competitive landscape with company market share analysis and in-depth profiles of key market participants. Key regional markets analyzed and reported in this study include:
·         North America
·         Europe
·         Asia Pacific
·         RoW

Critical elements of the report include:
·         Industry dynamics
·         Market challenges and opportunities
·         Technology & regulatory trends
·         Market estimate and forecast
·         Regional trends
·         Competitive trends
Prebook a Sample copy of This Report @ http://www.hexaresearch.com/sample/37
Why should you buy this report?
·         This report provides comprehensive analysis of the market including Porter’s and SWOT analysis
·         Complete identification and analysis of key industry dynamics including drivers, restraints, raw material trends and buyer behavior
·         The study provides technology landscape and regulatory trends for building strategy
·         Global and regional market estimates and forecast on volume and revenue basis for multiple market segments
·         Detailed competitive landscape of the market, with profiles of key companies

Browse Full Report @

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw    
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Monday, June 27, 2016

Apheresis Equipment Market Size, Share, Analysis, Growth and Forecasts to 2020: Hexa Research

Apheresis equipment market is expected to grow over the forecast period owing to the increasing prevalence of hemophilia, sickle cell anemia, blood cancer and rising demand for blood products. The other growth drivers of this market are lifestyle induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing geriatric population and awareness. These factors are expected to drive the market over the forecast period. Apheresis is process in which blood passes through an apparatus and the components of the blood get separated. The targeted components are separated and remaining components are returned to the circulation. For this whole procedure medical technology and extracorporeal therapy are used. The components which are extracted from the blood units are leukocytes, plasma and platelets. With the help of therapeutic apheresis, the components which are contributing towards diseases are removed from the blood. Stem cell harvesting, leukopheresis, plateletpheresis and plasmapheresis are the few examples of the disease inducing blood components. Familial hypercholesterolemia or FH is one of the examples of genetic disorders. It is further characterization into bad cholesterol LDL on the basis of high cholesterol. LDL-apheresis application is used for those patients who are not responding to regular medical treatment and patient suffering from rhabdomyolysis or breakdown of coronary heart disorder. Apheresis equipment is widely used for the blood with high in cholesterol. The other factor which is anticipated to drive the market over the forecast period are rising incidences of chronic diseases such as cancer and autoimmune diseases, favorable reimbursement policies, biopharmaceutical companies incresing demand for plasma, sophisticated healthcare infrastructure in developing economies, and increase in number of platelet donors.

Browse Detail Report with TOC @

Product Insights
Apheresis equipment market is segmented on the basis of product types into disposables, and devices. Among these, devices held the largest market share in 2013 in terms of revenue, as these devices prices are very high. Disposable medical devices usages rate is growing as it prevents infections such as bloodstream and it also slows down the incidence or cases rates of hospital acquired infections. Over the forecast period, apheresis equipment market is expected to grow at a faster rate. 
Application Insights
Apheresis equipment market is segmented on the basis of application into neurology, hematology, and renal diseases. Among these, neurology application held the largest market share in 2013, due to the rising plasma exchange coupled with majority of multiple sclerosis is increasing in U.S. Over the upcoming five years this application is expected to show fruitful CAGR.
Procedure Insights
Apheresis equipment market is segmented on the basis of procedure into erythrocytapheresis, photophereis, leukapheresis, plateletpheresis, LDL-apheresis, and plasmapheresis. Among these, plateletpheresis held the largest market share in 2013, owing to its uses in donor apheresis area, and its applicability is widespread. Photopheresis is the fastest growing procedure in 2013, as die to rising rate of graft versus host disease and scleroderma. Scleroderma mostly affects women four times more than man and it describes syndrome of dermatitis, enteritis, hepatitis and transplanted solid organs having a risk of chronic GVHD having unirradiated blood products, and lymphoid tissues. Over the forecast period plateletpheresis segment will witness lucrative growth rate. 
Technology Insights
Apheresis equipment market is segmented on the basis of technology into membrane centrifugation & filtration. Among these, centrifugation held the largest segment in 2013 owing to its use in apheresis of any of the blood components. Where-as, membrane technology is only restricted to plasma exchange. 
Request a Sample copy of This Report @ http://www.hexaresearch.com/sample/127
Regional Insights
Geographically, the Apheresis equipment market is studied with respect to four regions such as Asia Pacific, Europe, North America, and RoW. Among these, North America is dominating the whole market in 2013, as it has presence of technologically updated systems, strong research & development, various government initiatives & programs and high patient awareness levels in this region. The growing economies in Asia Pacific such as India and China region are expected to witness lucrative growth over the forecast period owing to the rising healthcare expenditure, and awareness about the hospital acquired infection. 
Competitive Insights
The major market players in the apheresis equipment market are Kawasumi Laboratories Inc., Hemacare Corporation, B. Braun Melsungen AG, Therakos Inc., Haemonetics Corp., Fenwal Inc., Terumo BCT Inc., and Asahi Kasei Kuraray Medical Co Ltd.
Table of Contents

Chapter 1. Executive Summary
1.1. Apheresis Equipment - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Apheresis Equipment Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Apheresis Equipment Market Dynamics
2.3.1. Market Driver Analysis.
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Apheresis Equipment - Company Market Share Analysis
2.7. Apheresis Equipment Market PESTEL Analysis, 2012

Browse Full Report @

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Wednesday, June 22, 2016

Sleep Apnea Devices Market Research - Global Industry Analysis, Size, Share and Growth Report by Hexa Research

Sleep apnea devices market is expected to grow over the forecast period owing to the increasing prevalence cardiovascular diseases, incidence of sleep apnea and rising obesity. The other drivers include growing awareness about stroke, hypertension, Type II adult onset diabetes, and sophisticated healthcare infrastructure. These factors are expected to drive the market over the forecast period. Introduction of advanced technology such as novel and efficient treatment methodologies and diagnosis has enhanced patient outcome over the past recent years. Sleep apnea devices demands are picking up due to increased stress & depression, long working hours, obesity, rise in anxiety levels, and high incidences of diabetes has led towards high sleep disorders. Demand in developed countries has got huge momentum as this market is in emerging stage owing to the sophisticated healthcare infrastructure and high awareness. Over the next five years, developing economies will witness healthy growth as awareness is increasing in both patients and medical fraternity. Therapeutic devices have a high potential for commercialization and development as there is a demand & need for effective treatment devices. Globally, sleep apnea devices market in 2013 was valued at $ 1.9 billion and over the forecast period it will be growing at a CAGR of over 10%. Over the forecast period sleep apnea devices market expected to grow due to increased investment by market leaders towards compact, efficient and comfortable therapeutic devices. There are some restraining factors attached along with this market such as reliability of therapeutic devices, limited reimbursement, and lack of patient compliance.

Product Insights
Sleep apnea devices market is broadly classified on the basis of product types into diagnostic devices and therapeutic devices. Among these, diagnostic devices held the largest share in 2013. Diagnostic devices include polysomnography (PSG) devices, actigraphy systems, respiratory polygraphs and single channel screening devices (pulse oximeters). Demand for PSG devices has increased a lot over the recent years as patient prefers to sleep at home rather than at lab, convenient to be tested at home, and cost effective. Due to the low cost, the demand for other products has also increased such as single channel screening devices, two channel screening devices, respiratory polygraphs, actigraphy systems. Therapeutic devices comprise of airway clearance systems, adaptive servo ventilation (ASV) device, oral appliances, oxygen devices and positive airway pressure (PAP) system. Among these, oral appliances is fastest growing segment as it is used for the treatment of moderate sleep apnea. For the treatment of OSA, oral appliances are used as per the physician prescription and operated by only ENT, dentist, oral surgeon or by expert in sleep apnea devices.

Regional Insights

Geographically, the sleep apnea devices market is studied by segmenting the market into North America, Europe, Asia Pacific and RoW. North America is dominating the whole market due to increased awareness of sleep apnea, rising disposable income, increasing obesity, sophisticated healthcare infrastructure and high insurance coverage. As per the recent report published in March 2014 by European Sleep Apnea Database (ESADA), it says that nearly 15,500 people are being registered as sleep apnea patients. Asia Pacific will witness lucrative growth rate over the forecast period due to increasing population, government initiatives and growing economy.

Request a Sample copy of This Report@ http://www.hexaresearch.com/sample/237

Competitive Insights

The major market players in the sleep apnea devices market are ResMed, Philips Respironics, DeVilbiss Healthcare, CareFusion, Natus Medical, Fisher & Paykel Healthcare and Weinmann Medical Devices.

Table of Contents

Chapter 1. Executive Summary
1.1. Sleep Apnea Devices - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Sleep Apnea Devices Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Sleep Apnea Devices Value Chain Analysis
2.4. Sleep Apnea Devices Market Dynamics
2.4.1. Market Driver Analysis
2.4.2. Market Restraint Analysis
2.5. Key Opportunities Prioritized
2.6. Industry Analysis - Porter's
2.7. Sleep Apnea Devices - Key Company Analysis, 2013
2.8. Sleep Apnea Devices Market PESTEL Analysis, 2013


About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Monday, June 13, 2016

Medical Gases and Equipment Market Size, Share, Analysis, Regional Outlook, Growth, Trends and Forecasts To 2020

The gases which have direct or indirect effect on medical treatment are known as medical gases and the equipment used to facilitate or supply medical gases into human body are called as medical gas equipment. Introduction of favorable medical norm such as removal of drug user fee and duties introduced by U.S. Food and Drug Administration Safety and Innovation Act in 2012 for promoting the growth of medical gases and its supporting equipment are expected to be the major drivers of the market over the forecast period. The act is likely to help the manufacturers to cut their product cost, file for IP rights and maximize their profit margin. Adding more, increasing geriatric population base coupled with increasing demand for global home healthcare devices are expected to propel the growth of the global medical gases and equipment market in coming five years.
Rising awareness in manufacturers and consumers about medical gases usage and safety are likely to trigger the growth of this market over the forecast period. Establishment of favorable medical association such as Welding Distribution Association (GAWDA), Medical Gas Association (MGA) and Compressed Gas Association (CGA) are anticipated to drive the market growth. Some of the factors like theft of medical cylinder & gases, and helium storage are pulling the growth of medical gases and equipment market in coming few years. The emerging nations provide significant growth opportunities for this gases market owing to a huge gap between the rising demands and limited supply of medical gases for treatment. Moreover, increasing incidences of health and respiratory diseases coupled with rising personal disposable income and medical reimbursement facilities are expected to boost the market over the forecasted period.

Product Insights

On the basis of products, the market is bifurcated into medical gases and medical gases equipment. Due to high cost of medical gases equipment dominated the entire medical gases and equipment market in 2013 but the medical gasesmarket is expected to witness fastest growth rate over the forecast period. The medical gas market is furthersegmented into oxygen, helium, nitrogen, lung gas, laser gas, anaerobic mixtures, helium oxygen gas mixtures, carbon dioxide, medical air and ethylene oxide. Among these the oxygen gas market was the dominant segment in 2014 owing to large scale application in medical treatments and rising incidences of respiratory diseases such as pulmonary diseases. The medical gas equipment market is further classified into medical air compressor, mask, manifolds and outlets. The medical air compressor market is expected to witness lucrative growth over the forecast period owing to its wide range of application such as gas cylinders.


Regional Insights

Geographically, the global medical gas market is studied under four main regions namely, North America, Europe, Asia Pacific and RoW. North America was the dominant market in 2013 and contributes about 41% of entire market share. Owing to presence of sophisticated technology in healthcare and favorable government regulations this market will continue to grow and maintain its leading position over the forecast period. Asia Pacific region is anticipated to show the highest growth rate over the forecast period due to introduction of various medical norms by medical administrations. Rising geriatric population base in japan and continuously developing economy of china are expecting to record highest CAGR by 2020.

Request a Sample copy of This Report @ http://www.hexaresearch.com/sample/47

Competitor Insights

In 2013, the entire market was dominated by air liquide with over 20% share. The firms are taking many business development strategies such as joint ventures, acquisitions, new products and geographical expansions. Some of the key markets players of the global medical gases and equipment markets are Air Products Continental, Praxair Inc., Matheson Tri-Gas Inc., Air Gas Inc., Air Products and Chemicals Inc., Medical Gas Solutions, BeaconmededaesLlc, and Linde Group.

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Medical Gas Equipment Industry Outlook
2.1 Market segmentation
2.2 Market Size and Growth Prospects
2.3 Medical Gas Equipment Market Dynamics
2.3.1 Market driver analysis
2.3.2 Market Restraint Analysis
2.4 Industry Analysis - Porter’s
2.5 Key opportunities prioritized
2.6 Global Medical Gas Equipment Market - PESTEL Analysis
2.7 Medical gases and equipment: Company market share analysis, 2013
2.8 Pipeline outlook
2.9 Microeconomic Factors Affecting Market Growth
2.9.1 Healthcare expenditure level trends
2.9.2 Healthcare establishment purchasing capacity trends
2.9.2.1 Rising awareness levels
2.9.2.2 Average hospitalization costs
2.9.2.3 Currency Considerations
2.9.2.4 Availability of Credit
2.9.3 U.S. consumer healthcare expenditure trend

Browse Full Report @

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com

Global Home Healthcare Device Market Growth, Trends and Forecasts to 2022: Hexa Research


Home healthcare device market is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of chronic diseases such as diabetes, respiratory diseases and cardiac disorders. Home healthcare devices are wide range of medical equipment, devices and drugs that are generally used in home for treating diseases and disorders by non-professional care givers such as family members or patient itself. Improvement in technology has made the applications of medical devices simpler and mobile which is expectedto drive the home healthcare devices market over the forecast period. Some other factors which have triggered the demand for these devices are increasing demand for minimal invasive devices, cost effectiveness in treatment of diseases at home rather than visiting hospitals & healthcare institutes, and acceptance of more home healthcare devices globally. Increasing number of people diagnosed for deadly diseases like diabetics, kidney disease, asthma and cardiac diseases are anticipated to drive the market for home healthcare devices and drugs. Rapid growth in geriatric population base, increasing government support in healthcare, increase in personal disposable income and huge investment in sunk cost are the triggering factors for the market growth over the forecast period. Improvement in technology has bought a revolutionary change in treatment of chronic diseases by making it safer, increasing its effectiveness and making it more convenient in handling by the patients or caretakers.

Browse Detail Report with TOC @

Product Insights

The global home healthcare device market is bifurcated into type of products/devices and services. On the basis of products, market is again classified into diagnostic and monitoring devices, therapeutic home healthcare devices, home mobility assist devices, and medical supplies. Diagnostic and monitoring healthcare devices are divided into blood glucose monitors, blood pressure monitors, temperature monitors, heart rate monitors, sleep apnea monitors, pregnancy test kits, coagulation monitors, pulse oximeter and pedometers. Therapeutic home healthcare devices is further classified into insulin delivery devices, CPAP devices, nebulizers, intravenous equipment and dialysis equipment, whereas home mobility devices are sub-segmented into wheelchairs, cranes and crutches. Among all these, home mobility devices are commonly useddevices in daily practices by patients. Devices like blood glucose and blood sugar monitors are likely to growth over the next decade.

Services Insights

On the basis of services, market is divided into rehabilitation services, telehealth & telemedicine services, respiratory therapy services, infusion therapy services and unskilled home healthcare services. Respiratory therapy services contributes significant share in home healthcare market owing to the increasing incidences of respiratory disorders. Telemedicine and telehealth services are anticipated to growth at highest rate owing to the increasing usage of technology and active online presence of these devices.

Regional Insights

Regionally, the entire home healthcare market is divided into four main regions namely, North America, Europe, Asia Pacific and RoW. North America dominated the home healthcare products, in 2013. Owing to the increasing investment in R&D by big pharmaceutical companies and availability of sophisticated technology, the market is anticipated to continue its dominance by 2020. Asia Pacific region is considered to be the fastest growing segment over next six years due to increasing awareness about latest technology and growing geriatric population. Emerging economies provide significant growth opportunity for the growth of this market owing to a large potential market which is lying idle and needed to be exploited, in order to capture maximum market share.

Prebook Sample copy of This Report @ http://www.hexaresearch.com/sample/253

Competitors Insights

Some of the key players of home healthcare device market are 3M Healthcare, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., GE Healthcare, Bayer AG, Beckton, Dickinson and Company, Cardinal Healthcare, Gentiva Health Services, Inc., Invacare Corporation, and Medtronic, Inc. to name a few. The market is highly competitive and firms are adopting many business strategies for development of their business.

Browse Full Report @

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com